2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel
- PMID: 11032599
- DOI: 10.1200/JCO.2000.18.20.3558
2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel
Comment in
-
Patients aged > or = 70 are at high risk for neutropenic infection and should receive hemopoietic growth factors when treated with moderately toxic chemotherapy.J Clin Oncol. 2001 Mar 1;19(5):1583-5. doi: 10.1200/JCO.2001.19.5.1583. J Clin Oncol. 2001. PMID: 11230505 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
